Evidence map›Paper›PMID 25451223›Full record

ArticleFEBS letters2014

GBF/Gea mutant with a single substitution sustains fungal growth in the absence of BIG/Sec7.

Herbert N Arst, Miguel Hernandez-Gonzalez, Miguel A Peñalva, Areti Pantazopoulou

Open access · hybridAbstract read
In one paragraph

Article in FEBS letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cell Biology of Hyphal Growth.Microbiology spectrum · 2017
    Review
  7. Article
  8. Article
  9. TRAPPII regulates exocytic Golgi exit by mediating nucleotide exchange on the Ypt31 ortholog RabERAB11.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Herbert N ArstSection of Microbiology, Department of Medicine, Imperial College London, London SW7 2AZ, United Kingdom; Centro de Investigaciones Biológicas, CSIC, Madrid 28040, Spain.
Miguel Hernandez-GonzalezCentro de Investigaciones Biológicas, CSIC, Madrid 28040, Spain.
Miguel A PeñalvaCentro de Investigaciones Biológicas, CSIC, Madrid 28040, Spain.
Areti PantazopoulouCentro de Investigaciones Biológicas, CSIC, Madrid 28040, Spain. Electronic address: apantazopoulou@cib.csic.es.
Centro de Investigaciones Biológicas Margarita Salas · ESImperial College London · GB

Funding

Wellcome TrustWellcome Trust 084660/Z/08/Z
6 · The paper itself

Abstract

Golgi Arf1-guanine nucleotide exchange factors (GEFs) belong to two subfamilies: GBF/Gea and BIG/Sec7. Both are conserved across eukaryotes, but the physiological role of each is not well understood. Aspergillus nidulans has a single member of the early Golgi GBF/Gea-subfamily, geaA, and the late Golgi BIG/Sec7-subfamily, hypB. Both geaA and hypB are essential. hypB5 conditionally blocks secretion. We sought extragenic hypB5 suppressors and obtained geaA1. geaA1 results in Tyr1022Cys within a conserved GBF/Gea-specific S(Y/W/F)(L/I) motif in GeaA. This mutation alters GeaA localization. Remarkably, geaA1 suppresses hypBΔ, indicating that a single mutant Golgi Arf1-GEF suffices for growth.

Indexed as

Amino Acid SubstitutionMutationAmino Acid MotifsAmino Acid SequenceAspergillus fumigatusFungal ProteinsGuanine Nucleotide Exchange FactorsIntracellular SpaceMolecular Sequence DataProtein TransportFungal ProteinsGuanine Nucleotide Exchange FactorsBIG/Sec7-subfamilyFungal secretionGBF/Gea-subfamilyGolgi Arf1-GEFs

Identifiers

PMID25451223
PMCPMC4266534
OpenAlexW1986552697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.